BrianEdwardFlowersMD

Ophthalmology • Fort Worth, TX

Glaucoma Related, Retinal Disease

Physician

Join to view full profile

Dr. Flowers is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Flowers' full profile

Already have an account?

Office
1201 Summit Ave
Fort Worth, TX 76102
Phone+1 817-332-2020

Fax+1 817-332-4797

Education & Training

Washington University/B-JH/SLCH ConsortiumResidency, Ophthalmology, 1994 - 1997
MedStar Health/Georgetown-Washington Hospital CenterInternship, Internal Medicine, 1993 - 1994
Johns Hopkins University School of MedicineClass of 1993

Certifications & Licensure

CA State Medical License 1997 - Present
TX State Medical License 1998 - 2026
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification IntelleChart EHR, MDIntelleSys, LLC, 2012-2013
Fellow (FAAO) American Academy of Ophthalmology

Clinical Trials

Multicenter Study Using Glaukos® Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract Surgery Start of enrollment: 2012 Jan 16
Completed
Not Applicable

Publications & Presentations

PubMed

9 citations
Suppression of Diurnal (9AM-4PM) IOP Fluctuations with Minimally Invasive Glaucoma Surgery: An Analysis of Data from the Prospective, Multicenter, Single-Arm GEMINI St...
Mark F. Pyfer, Mark J. Gallardo, Anita Campbell, Brian E. Flowers, Jaime E. Dickerson
Clinical Ophthalmology. 2021-09-24
159 citations
Prospective, Randomized, Controlled Pivotal Trial of an Ab Interno Implanted Trabecular Micro-Bypass in Primary Open-Angle Glaucoma and Cataract: Two-Year Results.
Thomas W. Samuelson, Steven R. Sarkisian, David M. Lubeck, Michael C. Stiles, Yi-Jing Duh
Ophthalmology. 2019-03-14
88 citations
The safety and efficacy of travoprost 0.004%/timolol 0.5% fixed combination ophthalmic solution.
Howard S. Barnebey, Silvia Orengo-Nania, Brian E. Flowers, John R. Samples, Sushanta Mallick
American Journal of Ophthalmology. 2005-07-01

Press Mentions

iSTAR Medical Receives U.S. FDA Approval to Start Pivotal Trial for MINIject in Glaucoma PatientsJuly 15th, 2021

Professional Memberships

American Academy of Ophthalmology - AAO
Fellow